sales@scalarmarketresearch.com |  +1-800-213-5170  (U.S./ Canada Toll-free) |  REGISTER |  SIGN IN

Home >> Reports >> fibroadenoma market

report

Fibroadenoma Market, by Types (Simple Fibroadenoma, Complex Fibroadenoma) Diagnosis (Physical Examination, Ultrasound Scan, Mammogram, Biopsy, Others) Treatment (Cryoablation, High Intensity Focused Ultrasound (HIFU), Drugs, Surgery, Others) End-user (Hospitals and Clinic, Diagnostic Centers, Others) – Global Revenue, Trends, Growth, Share, Size and Forecast to 2022

HC396 September 2017 100+ FREE 10% CUSTOMIZATION

Fibroadenomas are breast tumours not harmful in effect and can be characterized by stromal and epithelial tissue mixture. Fibroadenomas initiates from the glands producing more milk forming a solid lump. It is caused by the hormone imbalances and several symptoms related to this disease are firm, painless, mobile lump in woman’s breast. According to sources, fibroadenomas commonly occurs among young women in the age of 20s and 30s, even though they are mostly found in women despite of their age. These tumours grow very fast at the time of pregnancy, while at the time of menopause they shrink. Fibroadenomas augments the breast cancer risk of by one & a half times more than the women with no Fibroadenomas.

The report on the global fibroadenoma market uses the top-down and bottom-up approaches to define, analyze, and describe the market trends for the next five years. The report also tracks the emerging applications, innovative technologies, and mergers & acquisitions. It also focuses on the growth drivers and restraints for the key market players during the forecast period.

KEY BENEFITS OF THE REPORT

  • In-depth analysis of the market ecosystem and its impact on the revenue growth
  • Understanding of the strategies that are being adopted by the key players in this market to stay competitive
  • Valuable insights into the key technological and market trends impacting this market

KEY PREMIUM INDUSTRY INSIGHTS

  • The global market for fibroadenomas is augmenting owing to several factors including increasing usage of hormonal contraceptives that enhances fibroadenomas chances, greater screening rates, genetic predisposition, increasing awareness etc. Obesity also augments the chances of rising fibroadenoma breast cancer. The market restraining factors are the non-life intimidation nature of this disease, the self-determing nature of fibroadenomas etc.
  • Removing fibroadenomas is the suggested treatment if in case they keep growing but it has been found that these tumours shrink and stop growing itself without the help of any kind of treatment. These tumours are sometimes called breast mice owing to elevated mobility in women breast.
  • However, reimbursement environment along with the healthcare uncertainty reforms will hinder the global market for fibroadenomas in the years to come.

Regionally, the global fibroadenoma market segmented into Europe, North America, Asia-Pacific, and the Rest of the World. Among these, the US region accounts for utmost market share owing to positive insurance penetration that is leading to the scenario of reimbursement and huge expenditure on healthcare sector. Increasing market uptake of latest technology as well as devices in the this region is also an essential growth driver in the global market for fibroadenoma. Also, Europe region is followed by the US region owing to growing awareness and larger disposable income. Asia Pacific region is anticipated to be potential market in the years to ocme and is projecetd to be led by India and China.

RESEARCH METHODOLOGY

The research methodology for Scalar Market Research’s fibroadenoma market report utilizes a combination of top-down and bottom-up research formats. Our primary focus on continuous market tracking, rigorous fact-checking, data-triangulation, and multiple layers of quality control ensures high-quality data that can be leveraged for actionable research insights.

To know about the assumptions considered for the study, Download PDF Sample.

MARKET SEGMENTATION

This report analyzes the fibroadenoma market by the following segments:

  • Fibroadenoma Market, by Types
    • Simple Fibroadenoma
    • Complex Fibroadenoma
  • Fibroadenoma Market, by Diagnosis
    • Physical Examination
    • Ultrasound Scan
    • Mammogram
    • Biopsy
    • Others
  • Fibroadenoma Market, by Treatment
    • Cryoablation
    • High Intensity Focused Ultrasound (HIFU)
    • Drugs
    • Surgery
    • Others
  • Fibroadenoma Market, by End-users
    • Hospitals And Clinics
    • Diagnostic Centers
    • Others

KEY MARKET PLAYERS

Key players in the fibroadenoma market include:

  • IceCure Medical, Inc.
  • Alpinion Medical Systems Co., Ltd.
  • SonaCare Medical, LLC.
  • Insightec, Torrent Pharmaceuticals Ltd
  • Taj Pharmaceuticals Ltd.
  • Novartis Pharmaceuticals Limited
  • Torrent Pharmaceuticals Limited

GEOGRAPHIC COVERAGE AND ANALYSIS

This granular market research report covers the following geographic regions in great detail:

  • NORTH AMERICA
    • U.S.
    • Rest of North America
  • EUROPE
    • France
    • Germany
    • U.K
    • Rest of Europe
  • ASIA-PACIFIC
    • China
    • India
    • Japan
    • Rest of Asia-Pacific
  • REST OF THE WORLD
    • Latin America
    • Middle East & Africa

TRENDING RELATED REPORT

Stem Cell Therapy Market, by Treatments (Allogeneic Stem Cell Therapy, Autologous Stem Cell Therapy), Applications (Oncology, Eye Diseases, Central Nervous System Diseases, Musculoskeletal Diseases, Wound & Injuries, Metabolic Disorders, Cardiovascular Disorders, Immune System Disorders), End-users (Hospitals, Ambulatory Surgical Centers) - Global Revenue, Trends, Growth, Share, Size and Forecast to 2022


  1. MARKET OVERVIEW
    1. Market Definitions
    2. Research Methodology
    3. Market Segmentation
  2. EXECUTIVE SUMMARY
  3. MARKET DYNAMICS
    1. Drivers
    2. Restraints
    3. Opportunities
    4. Premium Industry Trends
  4. INDUSTRY ANALYSIS
    1. Value Chain Analysis
  5. FIBROADENOMA MARKET, BY TYPES
    1. Segment Share
    2. By Types
      1. Simple Fibroadenoma
      2. Complex Fibroadenoma
  6. FIBROADENOMA MARKET, BY DIAGNOSIS
    1. Segment Share
    2. By Diagnosis
      1. Physical Examination
      2. Ultrasound Scan
      3. Mammogram
      4. Biopsy
      5. Others
  7. FIBROADENOMA MARKET, BY TREATMENT
    1. Segment Share
    2. By Treatment
      1. Cryoablation
      2. High Intensity Focused Ultrasound (HIFU)
      3. Drugs
      4. Surgery
      5. Others
  8. FIBROADENOMA MARKET, BY END-USERS
    1. Segment share
    2. By End-users
      1. Hospitals and Clinics
      2. Diagnostic Centers
      3. Others
  9. FIBROADENOMA MARKET, BY GEOGRAPHY
    1. Segment Share
    2. North America
      1. By Regions
        1. U.S.
        2. Rest of North America
      2. By Types
      3. By Diagnosis
      4. By Treatment
      5. By End-users
    3. Europe
      1. By Regions
        1. France
        2. Germany
        3. U.K.
        4. Rest of Europe
      2. By Types
      3. By Diagnosis
      4. By Treatment
      5. By End-users
    4. Asia-Pacific
      1. By Regions
        1. China
        2. India
        3. Japan
        4. Rest of Asia-Pacific
      2. By Types
      3. By Diagnosis
      4. By Treatment
      5. By End-users
    5. Rest of the World
      1. By Regions
        1. Latin America
        2. Middle East & Africa
      2. By Types
      3. By Diagnosis
      4. By Treatment
      5. By End-users
  10. COMPETITIVE LANDSCAPE
    1. Market Positioning of Key Players, 2016
  11. KEY MARKET PLAYERS
    1. IceCure Medical, Inc.
      1. Overview
      2. Key Strategies
      3. Key Developments
    2. Alpinion Medical Systems Co., Ltd.
      1. Overview
      2. Key Strategies
      3. Key Developments
    3. SonaCare Medical, LLC.
      1. Overview
      2. Key Strategies
      3. Key Developments
    4. Insightec, Torrent Pharmaceuticals Ltd
      1. Overview
      2. Key Strategies
      3. Key Developments
    5. Taj Pharmaceuticals Ltd.
      1. Overview
      2. Key Strategies
      3. Key Developments
    6. Novartis Pharmaceuticals Limited
      1. Overview
      2. Key Strategies
      3. Key Developments
    7. Torrent Pharmaceuticals Limited
      1. Overview
      2. Key Strategies
      3. Key Developments
  12. SCALAR 360 DEGREE MARKET PERSPECTIVE
  13. APPENDIX
Please submit your enquiry below so our representative can get in touch with you
*
*
*
*
*
*

USA - CANADA TOLL FREE
+1-800-213-5170

EMAIL
sales@scalarmarketresearch.com

Benefits of Buying From Scalar

Unparalleled Expertise

Our industry experts hold inimitable know-how across wide range of industry verticals

Assured Quality

We deliver high-quality, real-time and data-driven industry insights to our clients

24x7 Analyst Support

We offer pre-purchase and post-purchase support from our industry experts

Privacy & Security

All your personal information and confidential details are safe and secure with us